期刊文献+

MC3在大肠癌组织中的表达及其临床意义

Expression of MC3 in the Colorectal Carcinoma Tissue and its Clinical Significance
原文传递
导出
摘要 为探讨MC3在大肠癌组织中的表达及其与临床病理参数的关系,采用免疫组化染色法检测192例大肠癌组织中MC3的表达情况,并分析其与年龄、性别、肿瘤分化程度、TNM分期、5年生存情况的相关性。结果显示,MC3在大肠癌组织中的阳性表达率为83.85%(161/192)。MC3的阳性表达与年龄、性别、M分期无关(P〉O.05),与肿瘤分化程度、T分期、N分期及5年生存率有关(Pd0.05)。结果表明,检测MC3的表达对了解大肠癌的生物学行为和判断预后有重要价值。 The objective of the study was to obtain the expression of MC3 in the colorectal carcinoma tissue (MC3 expression) and assess its pathological parameters. Immunohistochemical method was applied in the measurement of MC3 expression,and the correlationship of MC3 with age, gender, differentiation status, TNM staging and five-year survival was also analyzed. As results, the' rate of MC3 expression was 83.85% (161/192) ,there was no correlation between MC3 expression and age, gender and M staging( P 〉0.05), MC3 expression was correlated with differentiation, T staging, N staging and 5-year survival( P 〈0.05). It is concluded that MC3 expression is of important value in understanding the biological behavior of colorectal carcinoma and in judging prognosis.
出处 《中国肛肠病杂志》 2010年第6期12-13,共2页 Chinese Journal of Coloproctology
关键词 大肠癌 MC3 病理学 免疫组织化学 Colorectal carcinoma MC3 Pathology Immunohistochemistry
  • 相关文献

参考文献2

二级参考文献31

  • 1Jemal A, Tiwari RC, Marray T, et al. Cancer statistics 2004 CA Cancer J Clin ,2004, 54:8-29.
  • 2Maroun J, Ng E, Berthelot JM, et al. Lifetime costs of colon and rectal cancer management in Canada. Chronic Dis Can, 2003,24:91-101.
  • 3Fearon ER, Vogelstein B. A genetic model for colorectal tumourigenesis. Cell,1990,61:759-765.
  • 4Lynch HT, Smyrk TC, Watson P,et al. Genetics,natural history, tumour spectrum, and pathology of hereditary nonpolyposis colorectal cancer:an updated review. Gastroenterology,1993,104:1535-1549.
  • 5Ionov Y,Peinado MA, Malkhosyan S, et al. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature, 1993,363:558-561.
  • 6Papadopoulos N, Nicolaides NC, Wei YF, et al. Mutation of a mutL homolog in hereditary colon cancer. Science, 1994,263:1625-1629.
  • 7Markowitz S, Wang J, Myeroff L, et al.Inactivation of the type TGF-β receptor in colon cancer cells with microsatellite instability. Science, 1995,268:1336-1337.
  • 8Kane MF, Loda M, Gaida GM, et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell line. Cancer Res, 1997,57:808-811.
  • 9Ahuja N, Mohan AL, Li Q, et al. Association between CpG island and microsatellite instability in colorectal cancer. Cancer Res, 1997,57:3370-3374.
  • 10Toyota M. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA,1999,96:8681-8686.

共引文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部